AU-Camperdown-RPA
Camperdown, Australia
Hospital in Camperdown, New South Wales
50 Missenden Rd, Camperdown NSW 2050
911 Beds
About AU-Camperdown-RPA
The Royal Prince Alfred Hospital is a major public teaching hospital in Sydney, Australia, located on Missenden Road in Camperdown.
There are 911 beds in AU-Camperdown-RPA.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Stichting Hemato-Oncologie voor Volwassenen Nederland
2
Clinical Trials at AU-Camperdown-RPA
During the past decade, AU-Camperdown-RPA conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy
2019-03-01
2033-03-01
Recruiting
968
A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy
2019-12-20
2033-06-01
Recruiting
768
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AU-Camperdown-RPA"
#1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator and "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at AU-Camperdown-RPA
According to Clinical.Site data, the most researched conditions in "AU-Camperdown-RPA" are
"Acute Myeloid Leukemia" (2 trials) and "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials). Many other conditions were trialed in "AU-Camperdown-RPA" in a lesser frequency.
Clinical Trials Intervention Types at AU-Camperdown-RPA
Most popular intervention types in "AU-Camperdown-RPA" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "AG-120" (1 trials), "AG-221" (1 trials), "Gilteritinib" (1 trials), "Midostaurin" (1 trials) and "Placebo for AG-120" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AU-Camperdown-RPA
The vast majority of trials in "AU-Camperdown-RPA" are
2 trials for "All" genders.
Clinical Trials Status at AU-Camperdown-RPA
Currently, there are NaN active trials in "AU-Camperdown-RPA".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in AU-Camperdown-RPA,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in AU-Camperdown-RPA, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".